DE3788397T2 - Synthetische htlv-iii-peptid-zusammensetzungen und ihre verwendung. - Google Patents

Synthetische htlv-iii-peptid-zusammensetzungen und ihre verwendung.

Info

Publication number
DE3788397T2
DE3788397T2 DE3788397T DE3788397T DE3788397T2 DE 3788397 T2 DE3788397 T2 DE 3788397T2 DE 3788397 T DE3788397 T DE 3788397T DE 3788397 T DE3788397 T DE 3788397T DE 3788397 T2 DE3788397 T2 DE 3788397T2
Authority
DE
Germany
Prior art keywords
peptide compositions
htlv iii
iii peptide
synthetic
synthetic htlv
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE3788397T
Other languages
English (en)
Other versions
DE3788397T3 (de
DE3788397D1 (de
Inventor
Jonathan Rosen
Robert Naso
Ralph Arlinghaus
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ortho Pharmaceutical Corp
Original Assignee
Ortho Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25289969&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE3788397(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ortho Pharmaceutical Corp filed Critical Ortho Pharmaceutical Corp
Application granted granted Critical
Publication of DE3788397D1 publication Critical patent/DE3788397D1/de
Publication of DE3788397T2 publication Critical patent/DE3788397T2/de
Publication of DE3788397T3 publication Critical patent/DE3788397T3/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
DE3788397T 1986-03-24 1987-03-20 Synthetische htlv-iii-peptid-zusammensetzungen und ihre verwendung. Expired - Lifetime DE3788397T3 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84343786A 1986-03-24 1986-03-24
PCT/US1987/000577 WO1987006005A1 (en) 1986-03-24 1987-03-20 Synthetic htlv-iii peptides, compositions and uses thereof

Publications (3)

Publication Number Publication Date
DE3788397D1 DE3788397D1 (de) 1994-01-20
DE3788397T2 true DE3788397T2 (de) 1994-06-01
DE3788397T3 DE3788397T3 (de) 2003-11-27

Family

ID=25289969

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3788397T Expired - Lifetime DE3788397T3 (de) 1986-03-24 1987-03-20 Synthetische htlv-iii-peptid-zusammensetzungen und ihre verwendung.

Country Status (8)

Country Link
EP (1) EP0261224B2 (de)
JP (1) JPS63502904A (de)
AT (1) ATE98376T1 (de)
AU (3) AU7234387A (de)
DE (1) DE3788397T3 (de)
DK (1) DK175901B1 (de)
WO (1) WO1987006005A1 (de)
ZA (1) ZA872166B (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4879212A (en) * 1986-04-02 1989-11-07 United Biomedical Inc. Peptide composition and method for the detection of antibodies to HTLV-III
AU1334588A (en) * 1987-03-23 1988-09-22 Ortho Pharmaceutical Corporation Assay for detecting hepatitis antigens and aids antibodies
NO881151L (no) * 1987-03-27 1988-09-28 Syntello Ab Syntetisk hiv-1-antigen.
FI872409A0 (fi) * 1987-05-29 1987-05-29 Labsystems Oy Foerfarande foer detektering av hiv-1 motkroppar.
AU623097B2 (en) * 1987-10-09 1992-05-07 Academisch Ziekenhuis Bij De Universiteit Van Amsterdam Oligopeptides and their use for diagnostic and vaccination purposes for aids and arc
AU627701B2 (en) * 1987-10-28 1992-09-03 Euro-Diagnostica Ab Hiv peptides, artificial hiv antigens and immunoassay kits
SE8704185L (sv) * 1987-10-28 1989-04-29 Ferring Ab Nya peptider, artificiella antigener och immunoanalystestsatser
EP0323157A3 (de) * 1987-12-24 1990-07-25 The University Of Melbourne Antivirale Verbindungen und Methoden
SE8705197D0 (sv) * 1987-12-30 1987-12-30 Jonas Blomberg New peptides, two diagnostic methods using the peptides and a medicament based on the peptides
US6214537B1 (en) 1988-01-27 2001-04-10 Biochem Immunosystems, Inc. Synthetic peptides and mixtures thereof for detecting HIV antibodies
US6218102B1 (en) 1988-01-27 2001-04-17 Biochem Immunosystems, Inc. Synthetic peptides and mixtures thereof for detecting HIV antibodies
US6210874B1 (en) 1988-01-27 2001-04-03 Biochem Immunosystems, Inc. Synthetic peptides and mixtures thereof for detecting HIV antibodies
US5241047A (en) * 1988-12-08 1993-08-31 Biochem Pharma Inc. Synthetic peptides and mixtures thereof for detecting HIV antibodies
EP0328390B1 (de) * 1988-02-10 1994-09-14 Immulogic Pharmaceutical Corporation Peptidbehandlung von hartnäckigen Infektionskrankheiten
EP0330359A3 (de) * 1988-02-25 1991-06-05 Bio-Rad Laboratories, Inc. Zusammensetzung, verwendbar zur Diagnose und Behandlung von HIV-I-Infektion
FR2629459B1 (fr) * 1988-04-01 1990-12-21 Pasteur Institut Peptides pf11 a pf19 d'un retrovirus hiv - procede de synthese de ces peptides - leur utilisation notamment pour le diagnostic
US5268299A (en) * 1988-04-14 1993-12-07 Eastman Kodak Company Diluent composition useful in the detection of antibodies in assays
US5077198A (en) * 1988-04-14 1991-12-31 Eastman Kodak Company Diagnostic kit and method for rapid detection of antibodies
ZA896410B (en) * 1988-08-27 1990-05-30 Akzo Nv Synthetic peptides immunochemically reactive with hiv-antibodies
US5260189A (en) * 1988-12-20 1993-11-09 Immunodiagnostics, Inc. Synthetic HIV-like peptides their compositions and uses
US5439792A (en) * 1989-06-02 1995-08-08 Genetic Systems Corporation Cysteine thiol-protected peptides for use in immunoassays
AU652919B2 (en) * 1989-06-02 1994-09-15 Genetic Systems Corporation Cysteine thiol-protected peptides for use in immunoassays
US6083504A (en) * 1989-08-24 2000-07-04 Bioclonetics Incorporated Human monoclonal antibodies directed against the transmembrane glycoprotein (GP41) of human immunodeficiency virus-1 (HIV-1)
US5459060A (en) * 1989-08-24 1995-10-17 Bioclonetics Incorporated Human monoclonal antibodies directed against the transmembrane glycoprotein (gp41) of human immunodeficiency virus-1 (HIV-1)
US6248574B1 (en) 1989-12-13 2001-06-19 Avigdor Shaffermann Polypeptides selectively reactive with antibodies against human immunodeficiency virus and vaccines comprising the polypeptides
EP0438332B1 (de) * 1990-01-16 1998-04-08 Orgenics Ltd. Peptide, von Virus-HIV-Hüllen-Glycoproteinen abstammend, deren Verwendung zum Nachweis einer Infektion dieser Viren und für die Impfung gegen AIDS
FR2657017B1 (fr) * 1990-01-16 1995-08-18 Clonatec Sa Peptides derivant de la glycoproteine d'enveloppe du virus-hiv-1, leurs applications a la detection d'une infection due a ce virus et a la vaccination contre le sida.
JP4010560B2 (ja) 1992-07-20 2007-11-21 ドューク ユニバーシティー Ｈｉｖ複製を阻害する化合物
CA2125467C (en) * 1993-07-06 2001-02-06 Heinz Dobeli Process for producing hydrophobic polypeptides, proteins or peptides
FR2732346B1 (fr) * 1995-03-27 1997-05-30 Centre Nat Rech Scient Proteines mutees, codees par un gene env mute de lentivirus, fragments peptidiques inclus dans lesdites proteines, vecteurs d'expression exprimant lesdites proteines mutees et leurs applications
DE19720914A1 (de) * 1997-05-16 1998-11-19 Boehringer Mannheim Gmbh Verfahren zum Nachweis von HIV-Antikörpern und dazu verwendete Antigene
WO2010085763A1 (en) * 2009-01-23 2010-07-29 Inova Diagnostics, Inc. Methods for detecting antibodies associated with autoimmune diseases utilizing a three dimensionally heterogeneous peptide antigen

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4134792A (en) * 1976-12-06 1979-01-16 Miles Laboratories, Inc. Specific binding assay with an enzyme modulator as a labeling substance
JP2705791B2 (ja) * 1985-04-29 1998-01-28 ジエネテイツク システムズ コ−ポレイシヨン Ａｉｄｓ関連病の検出のための合成抗原
US4629783A (en) * 1985-04-29 1986-12-16 Genetic Systems Corporation Synthetic antigen for the detection of AIDS-related disease
JP2702911B2 (ja) * 1985-09-11 1998-01-26 ユナイテツド・バイオメデイカル・インコ−ポレ−テツド 合成ペプチド、並びにそれを用いたエイズおよびプリ・エイズの検出方法

Also Published As

Publication number Publication date
EP0261224B1 (de) 1993-12-08
JPS63502904A (ja) 1988-10-27
ZA872166B (en) 1988-10-26
AU7234387A (en) 1987-10-20
EP0261224A1 (de) 1988-03-30
EP0261224A4 (de) 1989-07-06
DE3788397T3 (de) 2003-11-27
AU8172094A (en) 1995-03-23
DE3788397D1 (de) 1994-01-20
ATE98376T1 (de) 1993-12-15
AU1130392A (en) 1992-06-04
EP0261224B2 (de) 2003-03-26
DK175901B1 (da) 2005-05-30
DK614987A (da) 1987-11-23
WO1987006005A1 (en) 1987-10-08
DK614987D0 (da) 1987-11-23

Similar Documents

Publication Publication Date Title
DE3788397T3 (de) Synthetische htlv-iii-peptid-zusammensetzungen und ihre verwendung.
DK626486D0 (da) Syntetiske antigener til afslaering af aids-relateret sygdom
DK0891982T3 (da) HIV-peptider
DK53687D0 (da) Peptid_fra htlv-iii-viruskappeprotein
AR222359A1 (es) Procedimiento para la purificacion de proteinas de elevado peso molecular
ATE231557T1 (de) Detektion des hepatis-c virus.
KR890002547A (ko) Hiv 감염의 치료 및 진단용 모노클로날항체 및 펩티드
DK597787A (da) Syntetisk antigen til paavisning af aids-relaterede sygdomme
DE3872754T2 (de) Nachweis von antikoerpern humaner immundefizienz-viren.
IT1207589B (it) Composizione di anticorpi monoclonali umani cross-protettivi.
ES2080047T3 (es) Peptidos hiv y metodos para la deteccion de hiv.
ATE94880T1 (de) Synthetische peptide, gegen diese gerichtete antikoerper und deren verwendung.
DE59508137D1 (de) Spezifische bindungssubstanzen für antikörper und deren verwendung für immunoassays oder vakzine
KR890700683A (ko) 인체 면역 결핍 바이러스에 대한 항체 검색 방법
FI92716C (fi) Uudet monoklonaaliset vasta-aineet IFN-omegalle, niiden valmistusmenetelmät ja niiden käyttö IFN-omegan puhdistamiseen ja osoittamiseen
FR2555577B1 (fr) Nouveaux derives de peptides, leur procede de preparation et leur emploi comme reactif biologique
FR2600068B1 (fr) Polypeptides de surfaces cellulaires, isoles et purifies, reconnus par les anticorps responsables de la pathogenie du lupus erythemateux dissemine (led), leur methode d'obtention et leur application au diagnostic ou led
FI883765A (fi) Antikroppar mot biologiskt aktiva polypeptider och deras anvaendning vid diagnostiska foerfaranden.

Legal Events

Date Code Title Description
8363 Opposition against the patent
8366 Restricted maintained after opposition proceedings